Neuroblastoma
Conditions
Interventions
Gold Standard:Diagnostic criteria for high-risk NB: children aged over 12 months with MYCN gene amplification or older than 18 months,clinical stage IV NB.
Index test:MYCN, 
BPTF, 
PHOX2B
Sponsors
Beijing Children's Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 18 Years
Inclusion criteria
Inclusion criteria: Meet the diagnostic criteria for high-risk NB; Younger than 18 years of age; Patients who have not started treatment before the first diagnosis of NB; Voluntarily sign informed consent; admit to the professional ward of our center and received high risk standardized NB treatment
Exclusion criteria
Exclusion criteria: Patients with serious complications who could not participate in the study; Patients with poor compliance to treatment or clinical studies; A patient whose treatment is discontinued or followed up after a non-medical event occurs during the course of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MYCN;plasma DNA;BPTF;PHOX2B; | — |
Countries
China
Contacts
Public ContactXiao Li Ma
Beijing Children's Hospital, Capital Medical University
Outcome results
None listed